OBJECTIVE: To define pain and physical function cutpoints that would, coupled with structural severity, define a surrogate measure of "need for joint replacement surgery," for use as an outcome measure for potential structure-modifying interventions for osteoarthritis (OA). METHODS: New scores were developed for pain and physical function in knee and hip OA. A cross-sectional international study in 1909 patients was conducted to define data-driven cutpoints corresponding to the orthopedic surgeons' indication for joint replacement. A post hoc analysis of 8 randomized clinical trials (1379 patients) evaluated the prevalence and validity of cutpoints, among patients with symptomatic hip/knee OA. RESULTS: In the international cross-sectional study, there was substantial overlap in symptom levels between patients with and patients without indication for joint replacement; indeed, it was not possible to determine cutpoints for pain and function defining this indication. The post hoc analysis of trial data showed that the prevalence of cases that combined radiological progression, high level of pain, and high degree of function impairment was low (2%-12%). The most discriminatory cutpoint to define an indication for joint replacement was found to be [pain (0-100) + physical function (0-100) > 80]. CONCLUSION: These results do not support a specific level of pain or function that defines an indication for joint replacement. However, a tentative cutpoint for pain and physical function levels is proposed for further evaluation. Potentially, this symptom level, coupled with radiographic progression, could be used to define "nonresponders" to disease-modifying drugs in OA clinical trials.
OBJECTIVE: To define pain and physical function cutpoints that would, coupled with structural severity, define a surrogate measure of "need for joint replacement surgery," for use as an outcome measure for potential structure-modifying interventions for osteoarthritis (OA). METHODS: New scores were developed for pain and physical function in knee and hip OA. A cross-sectional international study in 1909 patients was conducted to define data-driven cutpoints corresponding to the orthopedic surgeons' indication for joint replacement. A post hoc analysis of 8 randomized clinical trials (1379 patients) evaluated the prevalence and validity of cutpoints, among patients with symptomatic hip/knee OA. RESULTS: In the international cross-sectional study, there was substantial overlap in symptom levels between patients with and patients without indication for joint replacement; indeed, it was not possible to determine cutpoints for pain and function defining this indication. The post hoc analysis of trial data showed that the prevalence of cases that combined radiological progression, high level of pain, and high degree of function impairment was low (2%-12%). The most discriminatory cutpoint to define an indication for joint replacement was found to be [pain (0-100) + physical function (0-100) > 80]. CONCLUSION: These results do not support a specific level of pain or function that defines an indication for joint replacement. However, a tentative cutpoint for pain and physical function levels is proposed for further evaluation. Potentially, this symptom level, coupled with radiographic progression, could be used to define "nonresponders" to disease-modifying drugs in OA clinical trials.
Authors: Jean-Francis Maillefert; Gillian A Hawker; Laure Gossec; Nizar N Mahomed; Stefan Lohmander; Paul A Dieppe; Gustavo Zanoli; Marc C Hochberg; Maxime Dougados Journal: J Rheumatol Date: 2005-12 Impact factor: 4.666
Authors: G A Hawker; A M Davis; M R French; J Cibere; J M Jordan; L March; M Suarez-Almazor; J N Katz; P Dieppe Journal: Osteoarthritis Cartilage Date: 2008-04 Impact factor: 6.576
Authors: Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati Journal: Arch Intern Med Date: 2002-10-14
Authors: Kenneth D Brandt; Steven A Mazzuca; Barry P Katz; Kathleen A Lane; Kenneth A Buckwalter; David E Yocum; Frederick Wolfe; Thomas J Schnitzer; Larry W Moreland; Susan Manzi; John D Bradley; Leena Sharma; Chester V Oddis; Steven T Hugenberg; Louis W Heck Journal: Arthritis Rheum Date: 2005-07
Authors: Clifton O Bingham; J Chris Buckland-Wright; Patrick Garnero; Stanley B Cohen; Maxime Dougados; Silvano Adami; Daniel J Clauw; Timothy D Spector; Jean-Pierre Pelletier; Jean-Pierre Raynauld; Vibeke Strand; Lee S Simon; Joan M Meyer; Gary A Cline; John F Beary Journal: Arthritis Rheum Date: 2006-11
Authors: Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams Journal: N Engl J Med Date: 2006-02-23 Impact factor: 91.245
Authors: Laure Gossec; Gillian Hawker; Aileen M Davis; Jean Francis Maillefert; L Stefan Lohmander; Roy Altman; Jolanda Cibere; Philip G Conaghan; Marc C Hochberg; Joanne M Jordan; Jeffrey N Katz; Lyn March; Nizar Mahomed; Karel Pavelka; Ewa M Roos; Maria E Suarez-Almazor; Gustavo Zanoli; Maxime Dougados Journal: J Rheumatol Date: 2007-06 Impact factor: 4.666
Authors: David C Ayers; Wenjun Li; Leslie Harrold; Jeroan Allison; Patricia D Franklin Journal: Clin Orthop Relat Res Date: 2015-01 Impact factor: 4.176
Authors: Maria-Antonietta D'Agostino; Maarten Boers; John Kirwan; Désirée van der Heijde; Mikkel Østergaard; Georg Schett; Robert B Landewé; Walter P Maksymowych; Esperanza Naredo; Maxime Dougados; Annamaria Iagnocco; Clifton O Bingham; Peter M Brooks; Dorcas E Beaton; Frederique Gandjbakhch; Laure Gossec; Francis Guillemin; Sarah E Hewlett; Margreet Kloppenburg; Lyn March; Philip J Mease; Ingrid Moller; Lee S Simon; Jasvinder A Singh; Vibeke Strand; Richard J Wakefield; George A Wells; Peter Tugwell; Philip G Conaghan Journal: J Rheumatol Date: 2014-03-01 Impact factor: 4.666
Authors: Daniel L Riddle; William A Jiranek; Robert S Neff; Derek Whitaker; Jason R Hull Journal: Clin Orthop Relat Res Date: 2012-03-27 Impact factor: 4.176
Authors: Grace H Lo; Timothy E McAlindon; Jeffrey N Katz; Jeffrey B Driban; Lori Lyn Price; Charles B Eaton; Nancy J Petersen; Christie M Ballantyne; Maria E Suarez-Almazor Journal: Clin Rheumatol Date: 2017-06-01 Impact factor: 2.980
Authors: Cyrus Cooper; Jonathan D Adachi; Thomas Bardin; Francis Berenbaum; Bruno Flamion; Helgi Jonsson; John A Kanis; Franz Pelousse; Willem F Lems; Jean-Pierre Pelletier; Johanne Martel-Pelletier; Susanne Reiter; Jean-Yves Reginster; René Rizzoli; Olivier Bruyère Journal: Curr Med Res Opin Date: 2013-04-17 Impact factor: 2.580
Authors: Li Xu; Daichi Hayashi; Ali Guermazi; David J Hunter; Ling Li; Anton Winterstein; Klaus Bohndorf; Frank W Roemer Journal: Skeletal Radiol Date: 2013-07-11 Impact factor: 2.199